ICU Medical Inc
Research ICU Medical Inc (ICUI) on Bullrun: valuation model: 72.8% overvalued, market cap USD 4.10B, P/E 138.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerICUI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal72.8% overvalued
- Market capUSD 4.10B
- P/E138.5
- Financial periodQ2 2026
- RevenueUSD 551.68M
- Net incomeUSD 19.09M
- Free cash flowUSD 59.99M
- Gross margin42.6%
Valuation Snapshot
Bullrun's latest valuation model marks ICU Medical Inc as 72.8% overvalued; latest market cap is USD 4.10B; P/E is 138.5.
Peer valuation comparison
Latest P/E is 138.46x versus a Healthcare sector median of 24.6x (462.8% above).
Latest P/E is 138.46x versus a United States median of 23.85x (480.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 2.23B | USD 732.00K | USD 91.80M | 36.8% | 0.03 | USD 307.96M | USD 1.28B | USD 2.12B |
| FY2024 | USD 2.38B | -USD 117.69M | USD 124.66M | 34.6% | -4.83 | USD 308.57M | USD 1.58B | USD 1.97B |
| FY2023 | USD 2.26B | -USD 29.66M | USD 82.31M | 32.8% | -1.23 | USD 254.22M | USD 1.63B | USD 2.12B |
| FY2022 | USD 2.28B | -USD 74.29M | -USD 152.44M | 30.6% | -3.11 | USD 208.78M | USD 1.65B | USD 2.09B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 4.10B | 138.5 | n/a | n/a |
| 2025 | 2025-12-31 | USD 3.52B | 7133.5 | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.80B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.41B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 3.78B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 5.05B | 50.0 | n/a | n/a |
About ICU Medical Inc
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is ICU Medical Inc overvalued or undervalued?
Bullrun's valuation model currently marks ICU Medical Inc as 72.8% overvalued.
What is ICU Medical Inc's market cap?
ICU Medical Inc's market capitalization is USD 4.10B.
What is ICU Medical Inc's P/E ratio?
ICU Medical Inc's price-to-earnings (P/E) ratio is 138.5.
What does ICU Medical Inc do?
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products.